Vaxcyte shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Vaxcyte
Tip: Access up to 7 years of quarterly data
All positions including Vaxcyte held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaxcyte by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $14M | 398k | 36.02 |
| 2025-06-30 | $18M | 555k | 32.51 |
| 2025-03-31 | $19M | 514k | 37.76 |
| 2024-12-31 | $39M | 473k | 81.86 |
| 2024-09-30 | $47M | 408k | 114.27 |
| 2024-06-30 | $22M | 296k | 75.51 |
| 2024-03-31 | $7.4M | 108k | 68.31 |
| 2023-12-31 | $5.1M | 82k | 62.80 |
| 2023-09-30 | $3.8M | 75k | 50.98 |
| 2023-06-30 | $2.1M | 56k | 37.48 |
| 2023-03-31 | $2.1M | 56k | 37.48 |
| 2022-12-31 | $2.5M | 52k | 47.95 |
| 2022-09-30 | $831k | 35k | 24.00 |
| 2022-06-30 | $225k | 10k | 21.76 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas